We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+27.62%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$1.02B
AUM Growth
+$268M
Cap. Flow
+$26.2M
Cap. Flow %
2.58%
Top 10 Hldgs %
33.11%
Holding
117
New
41
Increased
22
Reduced
19
Closed
29

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$17.4M
2
MRK icon
Merck
MRK
+$14.1M
3
NET icon
Cloudflare
NET
+$13.1M
4
FCX icon
Freeport-McMoran
FCX
+$12.9M
5
NVO
Novo Nordisk
NVO
+$12M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$28.8M
2
META icon
Meta Platforms (Facebook)
META
+$14.7M
3
FWONK icon
Liberty Media Series C
FWONK
+$13.9M
4
PDD icon
Pinduoduo
PDD
+$11.7M
5
ASML icon
ASML
ASML
+$8.7M

Sector Composition

Rank Sector Weight
1 Healthcare 32.83%
2 Technology 25.25%
3 Industrials 9.81%
4 Consumer Discretionary 7.9%
5 Materials 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PEN icon
51
Penumbra
PEN
$12.8B
$7.36M 0.73%
33,000
– –
ASND icon
52
Ascendis Pharma A/S
ASND
$16.8B
$7.33M 0.72%
+48,500
New +$6.92M
COHR icon
53
Coherent
COHR
$74.2B
$7.27M 0.72%
+120,000
New +$6.58M
ITCI
54
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$7.27M 0.72%
105,000
+5,000
+5% +$344K
MRVL icon
55
Marvell Technology
MRVL
$196B
$7.09M 0.7%
+100,000
New +$6.85M
ELAN icon
56
Elanco Animal Health
ELAN
$11.1B
$6.95M 0.69%
427,188
+377,188
+754% +$5.9M
FERG icon
57
Ferguson
FERG
$49.8B
$6.4M 0.63%
29,300
-5,000
-15% -$996K
RH icon
58
RH
RH
$3.71B
$6.09M 0.6%
+17,500
New +$4.77M
TSLA icon
59
PUT
Tesla
TSLA
$1.3T
$5.8M 0.57%
+330
New +$64.5K
SDRL icon
60
Seadrill
SDRL
$2.7B
$5.78M 0.57%
115,000
-22,000
-16% -$999K
ROIV icon
61
Roivant Sciences
ROIV
$26.2B
$5.64M 0.56%
534,980
-205,000
-28% -$2.21M
CP icon
62
Canadian Pacific Kansas City
CP
$80.5B
$5.55M 0.55%
+63,000
New +$5.29M
AXSM icon
63
Axsome Therapeutics
AXSM
$10.9B
$5.43M 0.53%
68,000
+1,300
+2% +$109K
ENPH icon
64
Enphase Energy
ENPH
$5.53B
$5.32M 0.52%
+44,000
New +$5.13M
BBIO icon
65
CALL
BridgeBio Pharma
BBIO
$16.5B
$5.32M 0.52%
+1,720
New +$58.5K
XENE icon
66
Xenon Pharmaceuticals
XENE
$6.12B
$5.25M 0.52%
122,000
+28,766
+31% +$1.32M
IMVT icon
67
Immunovant
IMVT
$8.25B
$5.17M 0.51%
160,000
+40,000
+33% +$1.46M
DYN icon
68
Dyne Therapeutics
DYN
$4.9B
$4.97M 0.49%
+175,000
New +$3.96M
FUSN
69
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$4.97M 0.49%
233,000
+102,600
+79% +$1.23M
RBLX icon
70
Roblox
RBLX
$27B
$4.96M 0.49%
130,000
-40,000
-24% -$1.62M
CYTK icon
71
Cytokinetics
CYTK
$10.4B
$4.91M 0.48%
70,000
+19,000
+37% +$1.47M
TOST icon
72
Toast
TOST
$19.9B
$4.49M 0.44%
+180,000
New +$3.73M
KYMR icon
73
Kymera Therapeutics
KYMR
$8.94B
$4.1M 0.4%
+102,000
New +$3.65M
OSCR icon
74
Oscar Health
OSCR
$8.61B
$3.78M 0.37%
+254,232
New +$3.48M
TBBB icon
75
BBB Foods
TBBB
$4.92B
$3.66M 0.36%
+154,000
New +$3.3M
1 2
3
4 5

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
SC
Soundwatch Capital Rowayton, Connecticut $793M AUM 15.45% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
VCM
Vision Capital Management Portland, Oregon $792M AUM 18.17% 1-Year Est. Return

Atika Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Atika Capital Management held 117 positions worth $1.02B, up 36% from $747M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Atika Capital Management's Q1 2024 filing shows 41 new, 22 increased, 19 reduced and 29 closed positions. Its largest new stake was Merck: 114,000 shares worth $15M. The largest sale was Advanced Micro Devices, an estimated $28.8M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 30% a quarter earlier, followed by Technology and Industrials.

  • Atika Capital Management's largest Q1 2024 buy was Merck: 114,000 shares worth $15M.
  • Atika Capital Management added most to NVIDIA in Q1 2024, an estimated $17.4M increase.
  • Atika Capital Management's biggest Q1 2024 reduction was Advanced Micro Devices, cutting an estimated $28.8M.
  • Atika Capital Management fully exited Liberty Media Series C in Q1 2024, selling an estimated $13.9M.
  • Atika Capital Management's ten largest holdings make up 33% of its $1.02B portfolio in Q1 2024.
  • Atika Capital Management opened 41 new positions and closed 29 in Q1 2024.
  • Atika Capital Management's portfolio value rose 36% quarter-over-quarter to $1.02B.

Based on Atika Capital Management's 13F filing for Q1 2024, filed 14 May 2024.